Graeme Wald, OneVentures, provides an update on the Biomedical Translation Fund (BTF), designed to stimulate private sector investment in medical research
19 June 2017
Posted in — OneVentures
The $500 million Biomedical Translation Fund will make venture capital investments in promising biomedical innovations with commercialisation potential in Australia.
Author
Abbie Lewis
Abbie plays a key role in delivering OneVentures’ marketing, PR, community and branding initiatives, strengthening the firm’s identity and amplifying the visibility of our portfolio companies. Before joining OneVentures, Abbie worked at 89up in London, Europe’s first impact PR agency, where she contributed to global campaigns for NGOs.